A woman with primary liver cancer after nine years therapy with polyestradiol-phosphate is reported. The oestrogen was administered monthy by intramuscular injection for menopausal symptoms. This case suggests a possible association between long-term oestrogen therapy and the development of hepatic malignancy and also must direct attention to both hormone components in the evaluation of tumour development in users or oral contraceptives.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!